Fatty Liver Disease Tied to Higher Risk for Major Adverse Cardiovascular Events

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 28, 2026.

via HealthDay

THURSDAY, May 28, 2026 -- Hepatic steatosis is associated with greater noncalcified plaque burden (NCPB) and an increased risk for a major adverse cardiovascular event (MACE), according to a study published online May 20 in Clinical Gastroenterology and Hepatology.

Jan M. Brendel, M.D., from Harvard Medical School in Boston, and colleagues examined the relationship of hepatic steatosis with coronary plaque composition and MACE. The analysis included 3,637 patients evaluated for chest pain with coronary computed tomography (CT) angiography data.

The researchers found that 25.5 percent of participants had hepatic steatosis, which was associated with being slightly younger, more often male, having more cardiovascular risk factors, and a higher MACE rate (4.1 versus 2.5 percent). Hepatic steatosis was associated with greater NCPB (β = 0.15 percent) when adjusting for clinical risk factors. There was an association between hepatic steatosis and increased MACE risk independent of atherosclerotic cardiovascular disease risk score, obesity, obstructive stenosis, and NCPB (adjusted hazard ratio, 1.69). NCPB mediated 11 percent of the association between hepatic steatosis and MACE.

"Our findings highlight that fatty liver disease is not only a liver condition but also an important marker of heart disease risk," Brendel said in a statement. "Fatty liver disease can be detected on routine cardiac CT scans and could help guide earlier, preventive treatment."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-29 03:14

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords